Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 479Carcinoma, Non-Small-Cell Lung 436Prostatic Neoplasms 277Lung Neoplasms 169Stomach Neoplasms 138Neoplasms 112Squamous Cell Carcinoma of Head and Neck 109Head and Neck Neoplasms 97Neoplasm Metastasis 93Esophageal Neoplasms 70Ovarian Neoplasms 56Pancreatic Neoplasms 41Sarcoma 39Urinary Bladder Neoplasms 38Nasopharyngeal Carcinoma 32Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 26Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

Ifosfamide 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2pembrolizumab 1belinostat 1Vindesine 1Vincristine 1Topotecan 1Thoracoscopy 1Sucralfate 1Salts 1Robotic Surgical Procedures 1Rituximab 1Radiation 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Mitozytrex 1Mitomycin 1Methotrexate 1Iodized Oil 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Ethiodized Oil 1Docetaxel 1Dexamethasone 1Cytarabine 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mediastinal Neoplasms × Docetaxel × Clear all
NCT00315211 2018-08-20

Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

Aultman Health Foundation

Phase 2 Terminated
7 enrolled

Mediastinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡